UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
Turnover
54.76%
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+11.15%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$8.8B
AUM Growth
-$819M
(-8.5%)
Cap. Flow
-$1.49B
Cap. Flow
% of AUM
-16.94%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126
Avg Time Held Equity + Options
0.8
years
Top 10 Avg Time Held Equity + Options
0.1
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVLR
Avalara, Inc.
AVLR
|
+$364M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$355M |
| 3 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$273M |
| 4 |
STOR
STORE Capital Corporation
STOR
|
+$213M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$463M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$411M |
| 3 |
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$317M |
| 4 |
CDK
CDK Global, Inc.
CDK
|
+$290M |
| 5 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$276M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.43% |
| 2 | Financials | 19.77% |
| 3 | Healthcare | 15.9% |
| 4 | Miscellaneous | 8.89% |
| 5 | Real Estate | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Humacyte
HUMA
$100M
| $1.94M | 0.02% |
595,172
-504,828
| -46% | -$1.94M |
2021 Q4
3 quarters
|
|
602
Axalta
AXTA
$7.05B
| $1.94M | 0.02% |
92,070
| – | – |
2018 Q4
15 quarters
|
|
603
DELISTED
CERo Therapeutics
CERO
| $1.93M | 0.02% |
95
-10
| -10% | -$201K |
2021 Q4
3 quarters
|
|
604
DELISTED
Lionheart III Corp Class A Common Stock
LION
| $1.93M | 0.02% |
190,898
-19,111
| -9% | -$192K |
2021 Q4
3 quarters
|
|
605
Syntec Optics
OPTX
$282M
| $1.92M | 0.02% |
190,898
-19,111
| -9% | -$192K |
2022 Q1
2 quarters
|
|
606
Tigo Energy
TYGO
$68.1M
| $1.92M | 0.02% |
190,898
-19,111
| -9% | -$191K |
2021 Q3
4 quarters
|
|
|
SWSS
607
DELISTED
Clean Energy Special Situations Corp. Common stock
SWSS
| $1.9M | 0.02% |
381,796
-38,222
| -9% | -$190K |
2021 Q4
3 quarters
|
|
|
NGC
608
DELISTED
Northern Genesis Acquisition Corp. III
NGC
| $1.9M | 0.02% |
194,086
-19,430
| -9% | -$190K |
2021 Q2
5 quarters
|
|
|
FRBN
609
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $1.9M | 0.02% |
187,163
-18,737
| -9% | -$188K |
2022 Q2
1 quarter
|
|
610
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $1.89M | 0.02% |
187,163
-18,737
| -9% | -$188K |
2022 Q1
2 quarters
|
|
611
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
| $1.89M | 0.02% |
187,163
-18,737
| -9% | -$188K |
2022 Q1
2 quarters
|
|
612
PUT
Royal Caribbean
RCL
$73.7B
| $1.88M | 0.02% |
54,200
| – | – |
2021 Q2
5 quarters
|
|
613
ReNew
RNW
$2.51B
| $1.88M | 0.02% |
311,739
-1,713
| -0.5% | -$11.7K |
2022 Q2
1 quarter
|
|
|
CPTK
614
DELISTED
Crown PropTech Acquisitions
CPTK
| $1.88M | 0.02% |
188,968
-18,997
| -9% | -$188K |
2021 Q2
5 quarters
|
|
615
flyExclusive
FLYX
$62.6M
| $1.86M | 0.02% |
190,155
-19,036
| -9% | -$186K |
2021 Q3
4 quarters
|
|
|
ARYE
616
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
| $1.84M | 0.02% |
187,163
-18,737
| -9% | -$183K |
2022 Q1
2 quarters
|
|
617
Palantir
PLTR
$485B
| $1.83M | 0.02% |
225,000
-25,000
| -10% | -$222K |
2021 Q1
6 quarters
|
|
618
DELISTED
Bitcoin Depot
BTM
| $1.82M | 0.02% |
26,261
-2,629
| -9% | -$183K |
2022 Q2
1 quarter
|
|
|
LITT
619
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
| $1.82M | 0.02% |
186,126
-18,633
| -9% | -$182K |
2021 Q3
4 quarters
|
|
|
ITQ
620
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
| $1.81M | 0.02% |
182,323
-19,111
| -9% | -$189K |
2021 Q2
5 quarters
|
|
621
Kiniksa Pharmaceuticals
KNSA
$6.19B
| $1.81M | 0.02% |
+140,962
| New | +$1.61M |
2022 Q3
0 quarters
|
|
622
Johnson & Johnson
JNJ
$609B
| $1.81M | 0.02% |
+11,073
| New | +$1.87M |
2022 Q3
0 quarters
|
|
623
Stryker
SYK
$107B
| $1.81M | 0.02% |
8,925
-5,800
| -39% | -$1.22M |
2022 Q2
1 quarter
|
|
624
Neurocrine Biosciences
NBIX
$13.8B
| $1.81M | 0.02% |
17,003
-20,200
| -54% | -$2.05M |
2022 Q1
2 quarters
|
|
625
DELISTED
Enphys Acquisition Corp.
NFYS
| $1.79M | 0.02% |
183,827
-18,403
| -9% | -$179K |
2022 Q2
1 quarter
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2022 Portfolio in Review
As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
UBS O'Connor withdrew a net $1.49B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.
- UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
- UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
- UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
- UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
- UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
- UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
- UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.
Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.